logologo
QuantliQuantli

Fennec Pharmaceuticals Inc

FENC

NASDAQ

Biotechnology

$11.72

USD

-0.34 (-2.82%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $420.32M

Volume 106.9K

Price Target

$16.00$16.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $16.00 and a min estimate of $16.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$16.00

+$3.0 vs prior

Implied Upside

+36.5%

+25.6% vs prior

Analyst Covering

1

Unchanged vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Raghuram Selvaraju

HC Wainwright & Co.

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

CABA

Cabaletta Bio Inc

$2.75

+1.5%

RZLT

Rezolute Inc

$4.60

0.0%

PRLD

Prelude Therapeutics Inc

$5.55

+3.5%

EDIT

Editas Medicine Inc

$2.82

+0.4%

ENTA

Enanta Pharmaceuticals Inc

$13.16

-2.1%

PROK

Prokidney Corp

$1.33

-5.3%

LXEO

Lexeo Therapeutics Inc

$4.84

-2.4%

BNTC

Benitec Biopharma Inc

$12.56

0.0%

CMPX

Compass Therapeutics Inc.

$2.25

-0.4%